Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 699 | 8.160 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 559 | 6.660 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 443 | 5.280 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 177 | 5.070 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 424 | 3.980 |
Why?
|
| Acetabulum | 17 | 2020 | 192 | 3.220 |
Why?
|
| Reoperation | 65 | 2023 | 767 | 3.030 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 203 | 2.590 |
Why?
|
| Femur | 22 | 2019 | 310 | 2.550 |
Why?
|
| Prosthesis Design | 26 | 2022 | 394 | 2.450 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 48 | 1.820 |
Why?
|
| Knee Joint | 22 | 2022 | 577 | 1.740 |
Why?
|
| Aged | 75 | 2023 | 7586 | 1.680 |
Why?
|
| Humans | 129 | 2023 | 23569 | 1.610 |
Why?
|
| Osteolysis | 8 | 2015 | 113 | 1.470 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 366 | 1.410 |
Why?
|
| Middle Aged | 69 | 2022 | 8155 | 1.410 |
Why?
|
| Male | 79 | 2022 | 12776 | 1.340 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3122 | 1.340 |
Why?
|
| Postoperative Complications | 17 | 2018 | 837 | 1.320 |
Why?
|
| Bone Cements | 7 | 2020 | 79 | 1.290 |
Why?
|
| Female | 76 | 2022 | 13266 | 1.290 |
Why?
|
| Joint Diseases | 6 | 2021 | 95 | 1.270 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 283 | 1.240 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 3770 | 1.160 |
Why?
|
| Hip Joint | 14 | 2020 | 388 | 1.140 |
Why?
|
| Radiography | 21 | 2019 | 556 | 0.980 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 26 | 0.920 |
Why?
|
| Tibia | 10 | 2021 | 198 | 0.910 |
Why?
|
| Joint Instability | 8 | 2018 | 325 | 0.820 |
Why?
|
| Bone Resorption | 5 | 2014 | 76 | 0.820 |
Why?
|
| Vancomycin | 3 | 2018 | 52 | 0.800 |
Why?
|
| Hip Dislocation | 9 | 2016 | 59 | 0.790 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3095 | 0.750 |
Why?
|
| Pelvic Bones | 3 | 2012 | 17 | 0.710 |
Why?
|
| Tobramycin | 2 | 2018 | 8 | 0.700 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 9 | 0.690 |
Why?
|
| Gentamicins | 2 | 2018 | 18 | 0.690 |
Why?
|
| Synovial Fluid | 11 | 2017 | 82 | 0.680 |
Why?
|
| Tantalum | 8 | 2018 | 22 | 0.680 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 129 | 0.670 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1493 | 0.660 |
Why?
|
| Adult | 39 | 2022 | 7178 | 0.640 |
Why?
|
| Incidence | 9 | 2018 | 644 | 0.590 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 40 | 0.580 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 6 | 0.580 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 47 | 0.570 |
Why?
|
| Osteotomy | 8 | 2014 | 128 | 0.570 |
Why?
|
| Population Surveillance | 2 | 2018 | 107 | 0.560 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 37 | 0.550 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 80 | 0.550 |
Why?
|
| Osseointegration | 7 | 2016 | 64 | 0.540 |
Why?
|
| Device Removal | 7 | 2013 | 68 | 0.530 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.500 |
Why?
|
| Bupivacaine | 1 | 2016 | 40 | 0.490 |
Why?
|
| Risk Factors | 12 | 2019 | 1997 | 0.490 |
Why?
|
| Perioperative Care | 4 | 2017 | 42 | 0.480 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 71 | 0.480 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 33 | 0.480 |
Why?
|
| Metals | 4 | 2015 | 99 | 0.470 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 88 | 0.470 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 113 | 0.460 |
Why?
|
| Femur Head | 2 | 2006 | 51 | 0.450 |
Why?
|
| Prospective Studies | 9 | 2019 | 1535 | 0.450 |
Why?
|
| Decision Trees | 2 | 2011 | 14 | 0.420 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.420 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 299 | 0.410 |
Why?
|
| Dexamethasone | 1 | 2013 | 34 | 0.410 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 10 | 0.410 |
Why?
|
| Algorithms | 9 | 2022 | 317 | 0.390 |
Why?
|
| Bacteremia | 1 | 2013 | 98 | 0.390 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 38 | 0.380 |
Why?
|
| Ketamine | 2 | 2022 | 23 | 0.380 |
Why?
|
| Fractures, Bone | 3 | 2013 | 70 | 0.380 |
Why?
|
| Patient Readmission | 1 | 2013 | 118 | 0.380 |
Why?
|
| Poisoning | 1 | 2012 | 1 | 0.380 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 84 | 0.380 |
Why?
|
| United States | 14 | 2022 | 1837 | 0.370 |
Why?
|
| Skin Diseases | 1 | 2012 | 21 | 0.370 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 129 | 0.370 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 200 | 0.350 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 271 | 0.350 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 24 | 0.330 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 556 | 0.330 |
Why?
|
| Demography | 3 | 2019 | 58 | 0.310 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.310 |
Why?
|
| Quality of Life | 2 | 2011 | 565 | 0.310 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 18 | 0.310 |
Why?
|
| Bone Transplantation | 4 | 2012 | 156 | 0.300 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 32 | 0.300 |
Why?
|
| Recovery of Function | 8 | 2016 | 255 | 0.300 |
Why?
|
| Time Factors | 10 | 2020 | 1295 | 0.290 |
Why?
|
| Rheumatology | 3 | 2017 | 77 | 0.280 |
Why?
|
| Patient Discharge | 1 | 2009 | 146 | 0.280 |
Why?
|
| Surgeons | 4 | 2022 | 79 | 0.270 |
Why?
|
| Arthroplasty | 3 | 2022 | 117 | 0.260 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 294 | 0.260 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 48 | 0.260 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 92 | 0.230 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.230 |
Why?
|
| Cementation | 1 | 2005 | 30 | 0.230 |
Why?
|
| Occupational Diseases | 1 | 2005 | 22 | 0.230 |
Why?
|
| Risk Assessment | 8 | 2018 | 556 | 0.220 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 81 | 0.220 |
Why?
|
| Physical Examination | 4 | 2019 | 94 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2020 | 1466 | 0.210 |
Why?
|
| Debridement | 3 | 2013 | 74 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2018 | 209 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2019 | 202 | 0.200 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.200 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 49 | 0.200 |
Why?
|
| Pain Measurement | 4 | 2016 | 429 | 0.200 |
Why?
|
| Preoperative Care | 5 | 2016 | 112 | 0.190 |
Why?
|
| Medicare | 4 | 2013 | 107 | 0.190 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 31 | 0.190 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 71 | 0.190 |
Why?
|
| Logistic Models | 3 | 2018 | 357 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2002 | 21 | 0.190 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 9 | 0.190 |
Why?
|
| Porosity | 5 | 2017 | 55 | 0.190 |
Why?
|
| Femoral Fractures | 2 | 2019 | 32 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2018 | 505 | 0.180 |
Why?
|
| Postoperative Period | 3 | 2018 | 269 | 0.180 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 31 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 215 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 230 | 0.170 |
Why?
|
| Leukocyte Count | 7 | 2016 | 58 | 0.170 |
Why?
|
| Bone Nails | 1 | 2020 | 13 | 0.170 |
Why?
|
| Arthrodesis | 1 | 2020 | 33 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2017 | 61 | 0.160 |
Why?
|
| Prescriptions | 1 | 2020 | 16 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 8 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 66 | 0.160 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 52 | 0.160 |
Why?
|
| Polyethylene | 2 | 2021 | 95 | 0.160 |
Why?
|
| Illinois | 2 | 2018 | 222 | 0.160 |
Why?
|
| Disease Management | 3 | 2017 | 100 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 132 | 0.150 |
Why?
|
| Physician Assistants | 1 | 2019 | 10 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 28 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 324 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 34 | 0.150 |
Why?
|
| Body Mass Index | 5 | 2020 | 403 | 0.140 |
Why?
|
| Microspheres | 1 | 2018 | 24 | 0.140 |
Why?
|
| Creatinine | 1 | 2018 | 41 | 0.140 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 602 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 183 | 0.140 |
Why?
|
| Allografts | 2 | 2015 | 149 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 38 | 0.140 |
Why?
|
| Leukocytes | 1 | 2017 | 31 | 0.130 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 17 | 0.130 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 240 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 220 | 0.130 |
Why?
|
| Registries | 3 | 2022 | 179 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 31 | 0.130 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 144 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 37 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 113 | 0.130 |
Why?
|
| Methicillin | 1 | 2016 | 6 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 26 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 25 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 157 | 0.120 |
Why?
|
| Nasal Cavity | 1 | 2016 | 32 | 0.120 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 58 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 111 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 70 | 0.120 |
Why?
|
| Prevalence | 3 | 2013 | 395 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 62 | 0.120 |
Why?
|
| Patella | 2 | 2015 | 55 | 0.120 |
Why?
|
| Cell Count | 1 | 2015 | 72 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 12 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 244 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 16 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 453 | 0.120 |
Why?
|
| Nerve Block | 1 | 2016 | 62 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 168 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 270 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 61 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 20 | 0.110 |
Why?
|
| Length of Stay | 2 | 2013 | 305 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 88 | 0.110 |
Why?
|
| Decision Making | 2 | 2006 | 187 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 16 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1046 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2013 | 18 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2013 | 21 | 0.100 |
Why?
|
| Random Allocation | 1 | 2013 | 109 | 0.100 |
Why?
|
| Medicaid | 1 | 2013 | 36 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 72 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 48 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2012 | 7 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 127 | 0.100 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.090 |
Why?
|
| Braces | 1 | 2012 | 20 | 0.090 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 8 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2011 | 8 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 443 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 154 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 251 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 92 | 0.080 |
Why?
|
| Suction | 3 | 2015 | 36 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 132 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 169 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 23 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 112 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 28 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2009 | 66 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2020 | 68 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 482 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 23 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 129 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 110 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 7 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 194 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 12 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 23 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 14 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 23 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 20 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 391 | 0.070 |
Why?
|
| Chicago | 3 | 2018 | 818 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 72 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2005 | 65 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 8 | 0.060 |
Why?
|
| Joint Dislocations | 2 | 2018 | 50 | 0.060 |
Why?
|
| Surface Properties | 1 | 2006 | 107 | 0.060 |
Why?
|
| Southeastern United States | 1 | 2006 | 13 | 0.060 |
Why?
|
| Neutrophils | 2 | 2017 | 93 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 26 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 819 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 8 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 101 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 31 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 6 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 85 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 69 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 177 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 98 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 316 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2005 | 67 | 0.050 |
Why?
|
| Animals | 3 | 2007 | 3311 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 62 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 76 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 141 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 163 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 293 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 1747 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 126 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 33 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 78 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 112 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 431 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 66 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 583 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 55 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 105 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 276 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 45 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 99 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 88 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 289 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 15 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 348 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 170 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 57 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1178 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 80 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 33 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 172 | 0.030 |
Why?
|
| Spondylarthritis | 1 | 2017 | 3 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 1953 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 276 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 393 | 0.030 |
Why?
|
| Cost Savings | 1 | 2017 | 29 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 119 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 83 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 23 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 67 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 17 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 35 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 59 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 51 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 82 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 29 | 0.020 |
Why?
|
| California | 1 | 2012 | 35 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 603 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 43 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 5 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 214 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 27 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 169 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 108 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 6 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 648 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 35 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 749 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 105 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 41 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 908 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 32 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 20 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 105 | 0.020 |
Why?
|
| Research | 1 | 2006 | 36 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 124 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 237 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 6 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 196 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1050 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 105 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 323 | 0.010 |
Why?
|